{"transactions":[{"id":4214844,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock, par value $0.0001","published_at":"2017-09-07T20:17:10.000Z","date":"2017-09-07","kind":"sale","acquired":false,"shares":58712,"price":0.5283,"value":31017.5496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $0.52 and the highest price at which shares were sold was $0.545.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":950312,"source":{"system":"sec-edgar","filing":"0001209191-17-051978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117051978/doc4.xml","form_type":"4"}},{"id":4214843,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock, par value $0.0001","published_at":"2017-09-07T20:17:10.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":91907,"price":0.5365,"value":49308.1055,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $0.525 and the highest price at which shares were\nsold was $0.561.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information\nregarding the number of shares and prices at which the transaction was effected."}],"balance_after":1009024,"source":{"system":"sec-edgar","filing":"0001209191-17-051978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117051978/doc4.xml","form_type":"4"}},{"id":4214842,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock, par value $0.0001","published_at":"2017-09-07T20:17:10.000Z","date":"2017-09-05","kind":"sale","acquired":false,"shares":26181,"price":0.5571,"value":14585.4351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The lowest price at which shares were sold was $0.55 and the highest price at which shares were\nsold was $0.58.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information\nregarding the number of shares and prices at which the transaction was effected."}],"balance_after":1100931,"source":{"system":"sec-edgar","filing":"0001209191-17-051978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117051978/doc4.xml","form_type":"4"}},{"id":4219761,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-09-01T20:33:44.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":23200,"price":0.5682,"value":13182.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. The highest price at which shares were sold was $0.58 and the lowest price at which shares were sold was $0.56.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1127112,"source":{"system":"sec-edgar","filing":"0001209191-17-051112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117051112/doc4.xml","form_type":"4"}},{"id":4287157,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series C Convertible Preferred Stock, $0.0001 par value","published_at":"2017-06-09T21:55:54.000Z","date":"2017-06-09","kind":"exercise","acquired":false,"shares":332499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration."}],"balance_after":0,"derivative":{"underlying":"Common stock","underlying_shares":332499},"source":{"system":"sec-edgar","filing":"0001209191-17-039027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117039027/doc4.xml","form_type":"4"}},{"id":4287156,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":173331,"kind":"person","name":"Eliseev Alexey","position":1,"cik":"0001694380","reported_name":"Eliseev Alexey","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock, $0.0001 par value","published_at":"2017-06-09T21:55:54.000Z","date":"2017-06-09","kind":"exercise","acquired":true,"shares":332499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration."}],"balance_after":1150312,"source":{"system":"sec-edgar","filing":"0001209191-17-039027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694380/000120919117039027/doc4.xml","form_type":"4"}}]}